Holen Sie sich die Stockscreener-App
5.36
0.37%
0.02
Handel nachbörslich:
5.25
-0.11
-2.05%
Schlusskurs vom Vortag:
$5.34
Offen:
$5.27
24-Stunden-Volumen:
406.32K
Relative Volume:
1.10
Marktkapitalisierung:
$206.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.9007
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+11.20%
1M Leistung:
+70.70%
6M Leistung:
+29.47%
1J Leistung:
+194.51%
1-Tages-Spanne:
$5.20
$5.43
1-Wochen-Bereich:
$4.83
$5.879
52-Wochen-Spanne:
$1.75
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
5.36 | 206.03M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Will Protara Therapeutics Inc. stock attract more institutional investorsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
Custom watchlist performance reports with Protara Therapeutics Inc.July 2025 Reactions & Consistent Profit Trade Alerts - newser.com
How to forecast Protara Therapeutics Inc. trends using time seriesJuly 2025 Action & Stepwise Trade Signal Implementation - newser.com
Trend analysis for Protara Therapeutics Inc. this weekVolume Spike & Expert Curated Trade Setups - newser.com
Building trade automation scripts for Protara Therapeutics Inc.2025 Technical Overview & Safe Entry Zone Identification - newser.com
Measuring Protara Therapeutics Inc.’s beta against major indicesJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Will Protara Therapeutics Inc. price bounce be sustainable2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Statistical indicators supporting Protara Therapeutics Inc.’s strength2025 Technical Patterns & Weekly Momentum Picks - newser.com
Is Protara Therapeutics Inc. stock a safe haven asset2025 Retail Activity & High Yield Stock Recommendations - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policiesQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reportsPortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
How institutional ownership impacts Protara Therapeutics Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Exit strategy if you’re trapped in Protara Therapeutics Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
Will Protara Therapeutics Inc. bounce back from current supportJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Can a trend reversal in Protara Therapeutics Inc. lead to recoveryMarket Activity Summary & Real-Time Sentiment Analysis - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 2025Quarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Why hedge funds are buying Protara Therapeutics Inc. stockShare Buyback & Verified Momentum Stock Watchlist - newser.com
Protara Therapeutics' (TARA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Key resistance and support levels for Protara Therapeutics Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
Advanced analytics toolkit walkthrough for Protara Therapeutics Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Is Protara Therapeutics Inc. stock a contrarian buyProfit Target & Trade Opportunity Analysis - newser.com
Is Protara Therapeutics Inc. showing signs of accumulationWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Will Protara Therapeutics Inc. stock sustain high P E ratiosSwing Trade & Long-Term Safe Investment Ideas - newser.com
Will Protara Therapeutics Inc. (1KPA) stock see valuation expansion2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $4.41 Stock Options and RSUs in Key Employee Grant - Stock Titan
JonesTrading Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Is Protara Therapeutics Inc. forming a reversal pattern2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):